Reprocessed Devices | Medtech 360 | Market Analysis | US | 2016
Budget and sustainability challenges faced by health care facilities, as well as the rising acceptance of reprocessing among OEMs and physicians will support growth in the overall US market for reprocessed devices through 2024. Growth will be particularly strong in the reprocessed EP diagnostic catheter and reprocessed laparoscopic direct energy device segments, driven by their high per unit cost savings over OEM counterparts.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for reprocessed devices in the US across a 10-year period.